| |
| |
|
| Insider
Information: |
Faulkingham Dell |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
173,841 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$194,702 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
173,841 |
|
|
| Total
Value |
$194,702 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akebia Therapeutics, Inc. |
AKBA |
|
2022-03-01 |
173,841 |
2019-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CCO |
• – – |
2022-03-01 |
4 |
S |
$2.17 |
$14,555 |
D/D |
(6,705) |
173,841 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CCO |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
180,546 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CCO |
• – – |
2022-02-28 |
4 |
S |
$2.15 |
$13,961 |
D/D |
(6,479) |
130,546 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CCO |
• – – |
2021-04-01 |
4 |
S |
$3.40 |
$3,237 |
D/D |
(952) |
137,025 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
CCO |
• – – |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
9,152 |
137,977 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CCO |
• – – |
2021-03-01 |
4 |
S |
$3.40 |
$22,920 |
D/D |
(6,749) |
128,825 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
CCO |
• – – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
62,000 |
135,574 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CCO |
• – – |
2020-06-01 |
4 |
S |
$11.58 |
$74,413 |
D/D |
(6,426) |
73,574 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
CCO |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
80,000 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CCO |
• – – |
2019-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
